Twenty patients undergoing elective coronary surgery were randomized to receive either the prostacyclin analogue Iloprost (Zk 36374) 5 ng/kg/min for 30 minutes before cardiopulmonary bypass (CPB) increasing to 10 ng/kg/min during CPB, or placebo, to investigate any beneficial effect on platelet preservation, or protection of the central nervous system during clinical CPB. Originally 50 patients were to have entered the trial, but unacceptable hypotensive effects occu rred in five patients who received Iloprost, lead i ng to early data analysis. No significant improvement in platelet number, volume or function; bleeding time; arterial line filter δ dry weight; retinal microembolism; or neuropsychological function, attributable to Iloprost, could be identified. The role and optimal dose of Iloprost in clinical CPB remains to be established.
Get full access to this article
View all access options for this article.
References
1.
de Laval ME, Hill JD, Mielke CH et al. Blood platelets and extracorporeal circulation. J Thorac Cardiovasc Surg1975; 69: 144.
2.
Edmunds LH, Addonizio VPPlatelet physiology during cardiopulmonary bypass. In: Utley JR ed. Pathophysiology and techniques of cardiopulmonary bypass. Baltimore: Williams and Wilkins, 1982: 106-19.
3.
Allardyce DB , Yoshida SH, Ashmore PGThe importance of microembolism in the pathogenesis of organ dysfunction caused by prolonged use of the pump oxygenator. J Thorac Cardiovasc Surg1966 ; 52: 706-15.
4.
Dutton RC, Edmunds LH, Hutchinson JC, Roe BBPlatelet aggregate emboli produced in patients during cardiopulmonary bypass with membrane and bubble oxygenators and blood filters. J Thorac Cardiovasc Surg1974; 67: 258.
5.
Laufer N., Merin G., Grover NB et al. The influence of cardiopulmonary bypass on the size of human platelets. J Thorac Cardiovasc Surg1975; 70: 727-31.
6.
Harker LA, Malpass TW, Branson HE et al. Mechanism of abnormal bleeding in patients undergoing cardiopulmonary bypass: acquired transient platelet dysfunction association with selective α-granule release. Blood1980; 56: 824.
7.
Longmore DB, Bennett G., Gueirrara D. et al. Prostacyclin. A solution to some problems of extracorporeal circulation. Lancet1979; i: 1002-1005.
8.
Coppe D., Sobel M., Seamans L. et al. Preservation of platelet function and number by prostacyclin during cardiopulmonary bypass. J Thorac Cardiovasc Surg1981; 81: 274-78.
9.
Taylor KMProstacyclin therapy during cardiopulmonary bypass—is it beneficial ? Perfusion1987; 2: 1-7.
10.
Krause W., Krais Th. Pharmacokinetics and pharmacodynamics of the prostacyclin analogue Iloprost in man. Eur J Clin Pharmacol1986 ; 30: 61-68.
11.
Schillinger E. , Krais Th, Lehmann M, Stock G. Iloprost. In: Scriabine A ed. New cardiovascular drugs. New York: Raven Press, 1986: 209-31.
12.
Harder MP, van den Dungen Jjam, Wildevuur ChRH.A comparative study of platelet inhibitors during cardiopulmonary bypass. Schror (Ed.) Prostaglandins and other eicosanoids in the cardiovascular system. Proc. 2nd Int. Symp , Nurnberg- Furth1984, pp 298-302. Karger Basel1985.
13.
Huddleston CB, Hammon JW, Wareing TH et al. Amelioration of the deleterious effects of platelets activated during cardiopulmonary bypass . J Thorac Cardiovasc Surg1985; 89: 190-95.
14.
Addonizio VP , Fisher CA, Jenkin B. et al. Iloprost (ZK36374) a stable analogue of prostacyclin preserves platelets during simulated extracorporeal circulation . J Thorac Cardiovasc Surg1985 ; 89: 926-33.
15.
Addonizio VPThe effects of Iloprost on platelets during cardiopulmonary bypass operations . Proc Symp Iloprost (ZK36374) a novel prostacyclin analogue in cardiovascular disease. West Germany: Schering AG, 1984.
16.
Biggs R ed. Human blood coagulation, haemostasis and thrombosis. Second edition. Oxford: Blackwell Scientific Publications , 1976.
17.
Babson SR, Babson ALDevelopment and evaluation of a disposable device for performing simultaneous duplicate bleeding time determinations. Am J Clin Pathol1978; 70(3): 406-408.
18.
Faichney A. , Davidson KG, Wheatley DJ et al. Prostacyclin in cardiopulmonary bypass operations. J. Thorac Cardiovasc Surg1982 ; 84: 601-608.
19.
Blauth C., Arnold J., Kohner EM, Taylor KMRetinal microembolism during cardiopulmonary bypass demonstrated by fluorescein angiography. Lancet1986; ii: 837-39.
20.
Wilner AE, Rabiner CJ, Wisoff BG et al. Analogical reasoning and postoperative outcome. Arch Gen Psychiatry1976; 33: 255-59.
21.
Acker W.A computerised approach to psychological screening. Int J Man Machine Studies1982; 17: 1-9.
22.
Blauth C., Arnold J., Schulenburg WE, McCartney AC, Taylor KMCerebral microembolism during cardiopulmonary bypass: retinal microvascular studies in vivo using fluorescein angiography. J. Thorac Cardiovasc Surg1988 (in press).
